You are here
Appendix 3. Plasma and Recombinant Products Supplied Under Contract in 2017-18
TABLE 5.2 Plasma and recombinant products supplied under contract, 2017-18
|
Product Type
|
Name
|
Presentation
|
Supplier
|
Price
|
|---|---|---|---|---|
|
Albumin (plasma derived - domestic) |
Albumex |
20% 10ml |
CSL Behring (Australia) Pty Ltd |
$15.501 |
|
20% 100ml |
$67.621 |
|||
|
4% 50ml |
$15.501 |
|||
|
4% 500ml |
$67.621 |
|||
|
Factor VIIa |
NovoSeven |
1mg |
Novo Nordisk Pharmaceuticals Pty Ltd |
$1,316.65 |
|
2mg |
$2,633.28 |
|||
|
5mg |
$6,583.20 |
|||
|
8mg |
$10,533.14 |
|||
|
Factor VIII Anti-Inhibitor (plasma derived - imported) |
FEIBA |
500 IU |
Shire Australia Pty Limited |
$1,200.00 |
|
1000 IU |
$2,400.00 |
|||
|
2500IU |
$6,000.00 |
|||
|
Factor VIII (plasma derived - domestic) |
Biostate |
250 IU |
CSL Behring (Australia) Pty Ltd |
$218.141 |
|
500 IU |
$436.291 |
|||
|
1000 IU |
$872.571 |
|||
|
Factor VIII |
Advate |
250 IU |
Shire Australia Pty Limited |
$75.00 |
|
500 IU |
$150.00 |
|||
|
1000 IU |
$300.00 |
|||
|
1500 IU |
$450.00 |
|||
|
2000 IU |
$600.00 |
|||
|
3000 IU |
$900.00 |
|||
|
Factor VIII |
Eloctate |
250 IU |
Bioverativ Australia Pty Ltd |
* |
|
500 IU |
* |
|||
|
1000 IU |
* |
|||
|
2000 IU |
* |
|||
|
3000 IU |
* |
|||
|
Factor IX |
Alprolix |
250 IU |
Bioverativ AustraliaPty Ltd |
* |
|
500 IU |
* |
|||
|
1000 IU |
* |
|||
|
2000 IU |
* |
|||
|
3000 IU |
* |
|||
|
Factor VIII |
Xyntha |
250 IU |
Pfizer Australia Pty Ltd |
$90.00 |
|
500 IU |
$180.00 |
|||
|
1000 IU |
$360.00 |
|||
|
2000 IU |
$720.00 |
|||
|
3000 IU |
$1,080.00 |
|||
|
Factor IX (plasma |
MonoFIX |
1000 IU |
CSL Behring (Australia) Pty Ltd |
$872.571 |
|
Factor IX |
BeneFIX |
250 IU |
Pfizer Australia Pty Ltd |
$197.50 |
|
500 IU |
$395.00 |
|||
|
1000 IU |
$790.00 |
|||
|
2000 IU |
$1,580.00 |
|||
|
3000 IU |
$2,370.00 |
|||
|
Factor VIII |
Adynovate |
250 IU |
Shire Australia Pty Limited |
* |
|
500 IU |
* |
|||
|
1000 IU |
* |
|||
|
2000 IU |
* |
|||
|
Factor IX |
Rixubis |
250 IU |
Shire Australia |
$196.50 |
|
500 IU |
$393.00 |
|||
|
1000 IU |
$786.00 |
|||
|
2000 IU |
$1,572.00 |
|||
|
3000 IU |
$2,358.00 |
|||
|
Factor XI |
Factor XI |
1 IU |
CSL Behring (Australia) Pty Ltd |
$12.35 |
|
Factor XIII |
Fibrogammin |
250 IU |
CSL Behring (Australia) Pty Ltd |
$191.25 |
|
1250 IU |
$956.25 |
|||
|
Factor XIII |
NovoThirteen |
2500IU |
Novo Nordisk Pharmaceuticals Pty Ltd |
$30,000 |
|
Human prothrombin complex (plasma |
Prothrombinex |
500 IU |
CSL Behring (Australia) Pty Ltd |
$278.141 |
|
Fibrinogen Concentrate (plasma derived – imported) |
RiaSTAP |
1g |
CSL Behring (Australia) Pty Ltd |
$770.42 |
|
Human C1 esterase inhibitor concentrate (plasma derived – imported) |
Berinert |
500 IU |
CSL Behring (Australia) Pty Ltd |
$906.07 |
|
Protein C concentrate (plasma derived - imported) |
Ceprotin |
500 IU |
Shire Australia |
$1,075.00 |
|
1000 IU |
$2,150.00 |
|||
|
Antithrombin III concentrate (plasma derived - domestic) |
Thrombotrol VF |
1000 IU |
CSL Behring (Australia) Pty Ltd |
$1,407.021 |
|
Intravenous IVIg |
Intragam P |
3g/50ml |
CSL Behring (Australia) Pty Ltd |
$187.441 |
|
Intravenous IVIg (plasma derived – domestic) |
Intragam 10 |
2.5g/25ml |
CSL Behring (Australia) Pty Ltd |
$156.201 |
|
10g/100ml |
$624.791 |
|||
|
20g/200ml |
$1,249.591 |
|||
|
SCIg (plasma derived – domestic) |
Evogam |
16% 0.8g/5ml |
CSL Behring (Australia) Pty Ltd |
$49.981 |
15% 3.2g/20ml |
$199.931 |
|||
|
IVIg (plasma derived - imported) |
Flebogamma DIF |
5% 0.5g/10ml |
Grifols Australia Pty Ltd |
$22.50 |
|
5% 2.5g/50ml |
$112.50 |
|||
|
5% 5g/100ml |
$225.00 |
|||
|
5% 10g/200ml |
$450.00 |
|||
|
5% 20g/400ml |
$900.00 |
|||
|
10% 5g/50ml |
$225.00 |
|||
|
10% 10g/100ml |
$450.00 |
|||
|
10% 20g/200ml |
$900.00 |
|||
|
IVIg (plasma derived - imported) |
Privigen |
5g/50ml |
CSL Behring (Australia) Pty Ltd |
$225.00 |
|
10g/100ml |
$450.00 |
|||
|
20g/200ml |
$900.00 |
|||
|
40g/400ml |
$1,800.00 |
|||
|
SCIg (plasma derived - imported) |
Hizentra |
1g/5ml |
CSL Behring (Australia) Pty Ltd |
$57.43 |
|
2g/10ml |
$114.86 |
|||
|
4g/20ml |
$229.72 |
|||
|
10g 50ml |
$574.30 |
|||
|
Normal Ig NIg |
Normal Ig VF |
2ml (0.32gm) |
CSL Behring (Australia) Pty Ltd |
$31.651 |
|
5ml (0.80gm) |
$51.891 |
|||
|
CMV Ig |
CMV Ig |
1.5 million units |
CSL Behring (Australia) Pty Ltd |
$1,203.131 |
|
Hepatitis B Ig |
Hepatitis B Ig |
100 IU (2ml) |
CSL Behring (Australia) Pty Ltd |
$43.981 |
|
400 IU (5ml) |
$100.691 |
|||
|
Rh (D) Ig |
Rhophylac |
1500 IU |
CSL Behring (Australia) Pty Ltd |
$403.16 |
|
Rh (D) Ig - VF |
Rh (D) Ig |
250 IU |
CSL Behring (Australia) Pty Ltd |
$29.791 |
|
625 IU |
$74.441 |
|||
|
Tetanus Ig |
Tetanus Ig VF |
250 IU |
CSL Behring (Australia) Pty Ltd |
$43.471 |
|
4000 IU |
$695.481 |
|||
|
Zoster Ig |
Zoster Ig VF |
200 IU |
CSL Behring (Australia) Pty Ltd |
$272.751 |
*Extended half-life products supplied under limited and interim arrangements with no additional cost to the NBA budget.
1 The price does not include the starting plasma provided to CSL Behring (Australia) Pty Ltd by the Australian Red Cross Blood Service.